MEGGLE USA Inc. appoints Lewis Jackson as new CEO

PRESS RELEASE, 14th June, 2023

MEGGLE USA Inc. a global leader in pharmaceutical excipients, announced the appointment of Lewis Jackson as its new Chief Executive Officer. The experienced business leader will succeed Ruth Leinenbach and assume her responsibilities as of 12th June, 2023. The former management structure has led to a very successful and positive development of this affiliate over the last years. As Director Business Unit Excipients, Ruth Leinenbach will continue to work closely with MEGGLE USA and Mr. Lewis Jackson.

Mr. Jackson has many years of global business leadership experience in the pharmaceutical industry, having lived and held executive positions in the United States.

“We are delighted to welcome Lewis Jackson, an insightful and decisive leader
with a long track record of success, to MEGGLE USA.”

MEGGLE Business Unit Excipients Director, Ruth Leinenbach

“We are delighted to welcome Lewis Jackson, an insightful and decisive leader with a long track record of success, to MEGGLE USA. Mr. Jackson will bring a wealth of international pharmaceutical industry experience and a broad range of industry relationships. We are confident that Mr. Jackson is very well positioned to further grow the Excipient business for MEGGLE”, commented MEGGLE Business Unit Excipients Director, Ruth Leinenbach.

Mr. Jackson reports to the Managing Director of MEGGLE Ingredients, Marcus Hormuth.

Download the full PRESS RELEASE here: MEGGLE USA Inc. appoints Lewis Jackson as new CEO

Source: MEGGLE, Press Release | MEGGLE Business Unit Excipients | June, 2023